105
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Dose-Response Model for Lassa Virus

&
Pages 742-752 | Received 16 Jul 2007, Accepted 06 Nov 2007, Published online: 25 Jul 2008

REFERENCES

  • Borio , L , Inglesby , T Peters , J . 2002 . Hemorrhagic fever viruses as biological weapons . JAMA , 287 ( 18 ) : 2391 – 405 .
  • Buchana , R L , Smith , J L and Long , W . 2000 . Microbial risk assessment: Dose-relations and risk characterization . Internat J Food Microbiol , 58 : 159 – 72 .
  • Djavani , M , Yin , C Xia , L . 2000 . Murine immune response to mucosally delivered salmonella expressing lassa fever virus nucleoprotein . Vaccine , 18 : 1543 – 54 .
  • Geisbert , T W , Jones , S Fritz , E A . 2005 . Development of a new vaccine for the prevention of lassa fever . PloS Medicine , 2 ( 6 ) : e183
  • Haas , C N . 1983 . Estimation of risk due to low dose of microorganisms: A comparison of alternative methodologies . Am J Epidemiol , 118 ( 4 ) : 573 – 82 .
  • Haas , C N , Rose , J B and Gerba , C P . 1999 . Quantitative Microbial Risk Assessment , New York, NY, , USA : John Wiley and Sons, Inc .
  • Haas , C N , Madabusi , A T Rose , J B . 2000 . Development of a dose-response relationship for Escherichia coli O157:H7 . Internat J Food Microbiol , 1748 : 153 – 9 .
  • Ignatyev , G , Steinkasserer , A Streltsova , M . 2000 . Experimental study on the possibility of treatment of some hemorrhagic fevers . J Biotechnol , 83 : 67 – 76 .
  • Jahrling , P B . 1983 . Protection of lassa virus-infected guinea pigs with lassa-immune plasma of guinea pig, primate and human origin . J Med Virology , 12 : 93 – 102 .
  • Jahrling , P B , Smith , S Hesse , R A . 1982 . Pathogenesis of lassa virus infection in guinea pigs . Infection and Immunity , 37 : 771 – 8 .
  • Jahrling , P B , Clarence , J P Peters , J . 1984 . Enhanced treatment of lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys . J Infectious Dis , 49 ( 3 ) : 420 – 7 .
  • Lange , J V , Mitchel , S W McCormick , J B . 1985 . Kinetic study of platelets and fibrinogen in lassa virus-infected monkeys and early pathologic events in mopeia virus infected monkeys . Am J Tropical Med , 34 ( 5 ) : 999 – 1007 .
  • Lukashevich , I S , Patterson , S J Carrion , R . 2005 . A live attenuated vaccine for lassa fever made by reassortment of lassa and mopeia viruses . J Virology , 79 ( 22 ) : 13934 – 42 .
  • McCormick , J B , Mitchel , S W Kiley , M P . 1992 . Inactivated lassa virus elicits a non protective immune response in rhesus monkeys . J Med Virology , 56 ( 1–2 ) : 153 – 9 .
  • Nauta , M J . 2000 . Separation of uncertainty and variability in quantitative microbial risk assessment models . Internat J Food Microbiol , 57 : 9 – 18 .
  • Neuhauser , M and Hothorn , L A . 1999 . An exact Cochran-Amritage test for trend when dose-response shapes are a priori unknown . Computat Stat Data Anal , 30 ( 4 ) : 403 – 12 .
  • Rodas , J D , Lukashevich , I S Zapata , J C . 2004 . Mucosal arenavirus infection of primates can protect them from lethal hemorrhagic fever . J Med Virology , 73 : 424 – 35 .
  • Rotz , L D , Khan , A S Lillibridge , S C . 2002 . Public health assessment of potential biological terrorism agents . Emerging Infectious Dis J , 8 ( 2 ) : 225 – 30 .
  • Sbrana , E , Mateo , R I Xiao , S Y . 2006 . Clinical laboratory, virologic, and pathologic changes in hamsters experimentally infected with pirital virus (arenavirtidae): A rodent model of lassa fever . Am J Tropical Med Hyg , 74 ( 6 ) : 1096 – 102 .
  • Soller , J A . 2006 . Use of microbial risk assessment to inform the national estimate of acute gastrointestinal illness attributable to microbes in drinking water . J Water Health , 4 ( Suppl 2 ) : 165 – 86 .
  • Stephenson , E H , Larson , A W and Dominik , J W . 1984 . Effect of environmental factors on induced lassa virus infection . J Med Virology , 14 : 295 – 303 .
  • Teunis , P F and Havelaar , A H . 2000 . The beta Poisson dose response model is not a single-hit model . Risk Anal , 20 ( 4 ) : 513 – 20 .
  • WHO (World Health Organization) . 2005 . Retrieved February 1, 2007 from www.who.int/mediacenter/factsheets/fs179/en/ Fact Sheet. Lassa Fever

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.